Description générale
INN
Semaglutide
Codes ATC
Type de médicament
Biological agent
Historique des statuts LME
Ajouté en 2025
(TRS
1064)
pour
Type 2 diabetes mellitus
Wikipédia
DrugBank
Recommandations
Section
Hypoglycaemic agents
- Parenteral > General injections > SC: 0.25 mg in pre-filled pen injection solution; 0.5 mg in pre-filled pen injection solution; 1 mg in pre-filled pen injection solution; 2 mg in pre-filled pen injection solution; 4 mg in pre-filled pen injection solution
- Oral > Solid > tablet: 3 mg
- Parenteral > General injections > SC: 0.68 mg per mL in prefilled pen; 1.34 mg per mL in prefilled pen; 2.68 mg per mL in prefilled pen
Indications